Sadly, Latinos are 1.5 times more likely to develop Alzheimer’s disease than whites.
Across the board, Latinos are underrepresented in clinical research. Without Latino representation in Alzheimer’s clinical trials, researchers cannot find treatments that work best for this population.
Researchers also must understand and address the differential role of Alzheimer’s among Latinos, and the impact of alcohol, sleep deprivation, diabetes, and more.
Let’s use #SaludTues on Tuesday, Oct. 5, 2021, to tweet about the latest research and beneficial strategies and clinical trials to reduce Alzheimer’s disease and promote better brain health among Latinos and all people!
- WHAT: #SaludTues: Importance of Latino Participation in Clinical Trials in Alzheimer’s Disease
- TIME/DATE: 1-2 p.m. EST (Noon-1 p.m. CST), Tuesday, Oct. 5, 2021
- WHERE: On Twitter with hashtag #SaludTues
- HOST: @SaludAmerica
- CO-HOSTS: NIH ADEAR Center (@Alzheimers_NIH), Latinos Against Alzheimer’s (@UsA2_Latinos), Alzheimer’s Los Angeles(@AlzheimersLA), Public Health Maps (@PublicHealthMap)
We’ll open the floor to your comments, tips, and stories as we explore:
- How big of a health problem is Alzheimer’s disease among Latinos?
- How can we help Latinos with Alzheimer’s and promote clinical trials among Latinos?
- What strategies, programs, campaigns, and policies are working to prevent Alzheimer’s and improve clinical trial participation?
Be sure to use the hashtag #SaludTues to follow the conversation on Twitter in English or Spanish. Share stories and resources to help prevent Alzheimer’s among Latinos and all people!
Click here to learn about Salud America! #SaludTues tweetchats, see upcoming and past tweetchats, and see how you can get involved.
The post #SaludTues Tweetchat 10/5: Importance of Latino Participation in Clinical Trials in Alzheimer’s Disease appeared first on Salud America.Recommend0 recommendationsPublished in Fuerza por la Salud